Please wait

Exhibit 107

Calculation of Filing Fee Table

Form S-8

(Form Type)

Arbutus Biopharma Corporation

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered Securities

Security Type			Security Class Title			Fee Calculation Rule			Amount Registered(1)			Proposed Maximum Offering Price Per Unit			Proposed Maximum Aggregate Offering Price			Fee Rate			Amount of Registration Fee
Equity			Common Shares, without par value, issuable under the Arbutus Biopharma Corporation 2016 Omnibus Share and Incentive Plan			Other			3,500,000(2)			$2.155(3)			$7,542,500(3)			0.00011020			$	831.18
Equity			Common Shares, without par value, reserved for issuance pursuant to Stock Option Award (Inducement Grant)			Other			500,000(4)			$2.26(5)			$ 1,130,000(5)			0.00011020			$	124.53
Total Offering Amounts															$	8,672,500					$	955.71
Total Fee Offsets																					—
Net Fee Due																					$	955.71

(1)			In accordance with Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), this registration statement shall be deemed to cover any additional securities that may from time to time be offered or issued to prevent dilution resulting from stock splits, stock dividends or similar transactions.
(2)			Represents 3,500,000 common shares, without par value (the “Common Shares”), of Arbutus Biopharma Corporation (the “Registrant”) available for issuance under the Arbutus Biopharma Corporation 2016 Omnibus Share and Incentive Plan (the “2016 Plan”).
(3)			Estimated solely for the purpose of calculating the registration fee under Rule 457(c) and (h) of the Securities Act on the basis of the average of the high and low sales price per Common Share on July 28, 2023, as reported on the Nasdaq Global Select Market.
(4)			Represents 500,000 Common Shares of the Registrant that are issuable upon the exercise of the stock option award granted to the General Counsel and Chief Compliance Officer of the Registrant outside the 2016 Plan as an inducement material to his entry into employment with the Registrant in accordance with Nasdaq Listing Rule 5635(c)(4) (the “Inducement Option Award”).
(5)			Estimated in accordance with Rule 457(h) of the Securities Act solely for the purpose of calculating the registration fee based on the exercise price of the Inducement Option Award.